NCT06355050View on ClinicalTrials.gov

Ultrahypofractionated, Adaptive Radiation Therapy of Prostate Cancer

Not yet recruitingOBSERVATIONAL
Enrollment

150

Participants

Timeline

Start Date

September 15, 2025

Primary Completion Date

September 30, 2027

Study Completion Date

September 30, 2032

Conditions
Prostate CancerAdaptive RadiotherapyQuality of Life
Trial Locations (1)

Unknown

Department of Radiotherapy and Radiation Oncology, Jena University Hospital, Jena

All Listed Sponsors
collaborator

University Hospital Schleswig-Holstein

OTHER

collaborator

Klinikum Stuttgart

OTHER

collaborator

University Medical Center Göttingen

UNKNOWN

collaborator

Kantonsspital Aarau

OTHER

collaborator

Hirslanden Stephanshorn

UNKNOWN

collaborator

Universitätsklinik Würzburg

UNKNOWN

collaborator

Radiologische Allianz Hamburg

UNKNOWN

lead

Jena University Hospital

OTHER

NCT06355050 - Ultrahypofractionated, Adaptive Radiation Therapy of Prostate Cancer | Biotech Hunter | Biotech Hunter